Neurocrine Biosciences (NBIX) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Neurocrine Biosciences.
Bought (12 mo)
$0
Sold (12 mo)
$80,206,950
Insiders Buying (12 mo)
0
Insiders Selling (12 mo)
15
Form 4 Filings (All Time)
388
Most Recent Sale
November 3, 2026
George J Morrow
Director
$2,335,982
Buys (90d)
0
Sells (90d)
4
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-11-03 | Morrow George J | Director | Sell | $2,335,982 | — |
| 2026-11-03 | Gano Kyle | CEO | Exercise | — | +0.2% |
| 2026-09-15 | Abernethy Matt | CFO | Sell | $363,285 | — |
| 2026-09-15 | Boyer David W. | Officer | Sell | $130,051 | +7.7% |
| 2026-09-15 | Benevich Eric | Officer | Award | — | +4.3% |
| 2026-09-15 | Cooke Julie | Officer | Award | — | +6.8% |
| 2026-09-15 | Delaet Ingrid | Officer | Award | — | +11.1% |
| 2026-09-15 | Gorman Kevin Charles | Director | Award | — | +1.3% |
| 2026-09-15 | Gano Kyle | CEO | Award | — | +2.4% |
| 2026-09-15 | Lippoldt Darin | Officer | Award | — | +3.6% |
| 2026-09-15 | Keswani Sanjay Chandru | Officer | Award | — | +50.2% |
| 2026-09-15 | Onyia Jude | Officer | Award | — | +7.2% |
| 2026-09-11 | Benevich Eric | Officer | Sell | $333,030 | +1.6% |
| 2026-09-04 | Sherwin Stephen A | Director | Other | — | -6.3% |
Sign up free to view more insider trades.